# Preventing COVID-19 Complications With Low- and High-dose Anticoagulation

> **NCT04345848** · PHASE3 · TERMINATED · sponsor: **University Hospital, Geneva** · enrollment: 160 (actual)

## Conditions studied

- COVID
- Sars-CoV2

## Interventions

- **DRUG:** Enoxaparin

## Key facts

- **NCT ID:** NCT04345848
- **Lead sponsor:** University Hospital, Geneva
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-04-28
- **Primary completion:** 2021-06-02
- **Final completion:** 2021-06-02
- **Target enrollment:** 160 (ACTUAL)
- **Why stopped:** Low recruitement
- **Last updated:** 2021-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04345848

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04345848, "Preventing COVID-19 Complications With Low- and High-dose Anticoagulation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04345848. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*